Clinical Trials
Akeso's Cadonilimab Granted NMPA Acceptance for First-Line Gastric Cancer Treatment.
This will be the second indication for which cadonilimab has received approval in China, following its use as a monotherapy treatment for recurrent or...
January 08, 2024 | News
Belief BioMed Completes First Dosing in Hemophilia A Trial
BBM-H803 is Belief BioMed's first gene therapy for the treatment of hemophilia A and is the company's second product which has obtained IND approval from t...
January 04, 2024 | News
Sciwind Biosciences Reports Positive Phase 3 Results for Ecnoglutide in Chinese Type 2 Diabetes Trial
Study participants receiving 0.6 and 1.2 mg ecnoglutide once weekly for 24 weeks achieved HbA1c reductions of 1.96 and 2.43% from baseline, ...
January 03, 2024 | News
MediLink Therapeutics Partners with Roche for Oncology Antibody Drug Conjugate
Under the terms of the agreement, MediLink will grant Roche exclusive global rights for the development, manufacturing, and commercialization of MediLink's...
January 03, 2024 | News
NeuroBo Pharma Seeks FDA Approval for Obesity Treatment Trial
NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, anno...
January 02, 2024 | News
Alcresta Therapeutics Receives FDA Clearance for RELiZORB® Cartridge
Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel enzyme-based products, announced 510(...
January 02, 2024 | News
Mundipharma Greenlights European Approval for REZZAYO® in Treating Adult Invasive Candidiasis
The approval is based on the positive results of the pivotal Phase III ReSTORE clinical trial and is supported by STRIVE's Phase II clinical trials and a...
January 01, 2024 | News
Elpiscience, Astellas Ink Deal for Novel Bispecific Macrophage Engager
The two companies will collaboratively conduct early-stage research for these two programs. Elpiscience will also grant Astellas the right to add up ...
January 01, 2024 | News
TiumBio Raises KRW 38.5B for Upcoming Clinical Data
The proceeds will fund its robust clinical programs and bolster TiumBio's financial position. Data read-outs from a Phase 2 trial of merigolix...
January 01, 2024 | News
Recbio's REC610 Shingles Vaccine Shows Positive Interim Trial Results in the Philippines
Previously, the Company conducted a GSK Shingrix® active-controlled FIH clinical trial of REC610 in the Philippines. The Interim Analysis (IA) res...
December 29, 2023 | News
Clover's SCB-219M Shows Positive Phase I Results for Chemotherapy-Induced Thrombocytopenia (CIT) Treatment
--All CIT patients maintained platelet counts >75 x 109/L at 1-week following chemotherapy plus a single dose of SCB-219M, with durable responses t...
December 29, 2023 | News
Innovent and Xuanzhu Collaborate on Clinical Trial for Combined Therapy in Chinese Solid Tumor Treatment
Under the agreement, Innovent will supply sintilimab for the collaborated clinical trial. Xuanzhu Biopharma will conduct a Phase 1b clinical stud...
December 29, 2023 | News
Biocytogen and CtM Bio Advance in Developing Multi-Specific T Cell Engager against WT1/HLA-A02
In just one year since the start of the collaboration, the companies have identified a WT1/HLA-A02-specific T cell engager (WT1xCD3x4-1BB tri-specific anti...
December 28, 2023 | News
Nectin Therapeutics Expands Clinical Trial to Israel, Progresses Swiftly
Nectin Therapeutics Ltd., (Nectin), a biotechnology company developing novel targeted immunotherapies that address resistance to approved immune oncology t...
December 27, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
